At the IGTP TODAY
The Covergel project to develop an innovative hydrogel applicable by endoscope has been recognized as the best project in the third Edition of the IDEA2 Global, an international mentoring programme developed by the Massachusetts Institute of Technology (MIT). Covergel was chosen from the 15 teams participating in the 2018 edition.
Tuesday 11 December saw the celebration of the 7th edition of the Pedrera Talents at the Casa Milà. The awards, sponsored by the Catalonia La Pedrera Foundation, in which the Germans Trias Hospital and the Hospital Clínic de Barcelona both participate, consist of public recognition and a grant after their medical residency for young specialist physicians and other health professionals so that they can dedicate themselves to research.
Researchers from the Digestive Inflammatory Pathology Research Group at the IGTP and the Spanish Network for Hepatic and Digestive Diseases (CIBEREHD) have identified key elements of the mechanism behind the failure of steroid treatments for ulcerative colitis in some patients. Treatment failure is one of the main obstacles in the management of this disease and the new findings could help prevent treatment failure and allow for more efficient rescue therapies when needed. The study also identifies a possible biomarker to predict which patients might suffer treatment failure. The research was led by Dr. Eugeni Domènech and Dr. Josep Manyé, and published recently in the Journal of Crohn's and Colitis.
The construction company CBC already has its Christmas present for its staff and clients this year; the children's story "El Viaje de Crohn", a book written by Laura Marin a specialist nurse for this type of illness who works in the Digestive Inflammatory Pathology Research Group at the IGTP. All the proceeds will go towards the group's research effort.
Dr Rafael de Cid joined the institute in 2012 as the Scientific Director of the GCAT. Since then, the Project has been successfully set up and is now seeing the first research results. We asked him about the six publications that have appeared so far this year and what GCAT has in the pipeline.
The Urological Tumour Group of the Catalan Institute of Oncology (ICO-B·ARGO) at the Germans Trias i Pujol Research Institute (IGTP) led by Dr Albert Font Pous in collaboration with the Urology and Radiology Service at the Germans Trias i Pujol Hospital have joined the IRONMAN Project this November. The project was created and is being mainly financed by the Movember Foundation.
Today over 200 students from 7 centres in Badalona studying the technical or scientific baccalaureate, or vocational training course in healthcare visited the Can Ruti Campus. This year young researchers from 6 research institutions and the Universitat Autònoma de Barcelona gave talks, workshops and guided tours explaining their passion for biomedical research.
This week Noa and her parents have visited the IGTP laboratories to present a symbolic cheque for the 5,311 euros raised to finance research into rare paediatric diseases by the IGTP Neuromuscular and Neuropaediatric Research Group. The money was collected at a charity football match on 12 October in the Municipality of Llefià.
The project, called "Innovation in Tuberculosis - INNOVA4TB", is promoted and coordinated by the research group Innovation in Respiratory Infections and Tuberculosis Diagnosis, led by Dr Jose Domínguez and Dr Cristina Prat. The proposal has received more than a million euros in funding from the 2018 call for Marie Skłodowska-Curie (MSCA) actions
In a recent collaborative work, led by researchers from IDIBELL-ICO (ProCURE, Oncobell programs), IDIAP Jordi Gol and GCAT (Genomes of Life, IGTP), the main diseases and associations that contribute significantly to the appearance of multimorbidity are identified. The study also points out inherited genetic factors that have an influence on the appearance of multimorbidity